MUSTARGEN (mechlorethamine HCl)
HODGKIN'S LYMPHOMA·+10
LUNDBECK INC.
Indication
Pericardial malignant effusion
Pericardial malignant effusion is an oncologic complication characterized by the abnormal accumulation of fluid within the pericardial sac due to direct tumor invasion, hematogenous or lymphatic metastasis, or, rarely, primary pericardial malignancy. Read more about Pericardial malignant effusion
14 drugs 14 manufacturers
Drugs that treat it
Common Pericardial malignant effusion therapies.
THIOTEPA
CARCINOMA OF BREAST·+6
WEST-WARD,INC.
TEPADINA (thiotepa)
ALKYLATING AGENTS·CARCINOMA OF BREAST·+6
AMNEAL BIOSCIEN
THIOTEPA
ALKYLATING AGENTS·CARCINOMA OF BREAST·+6
DR.REDDY'S LAB
THIOTEPA
ALKYLATING AGENTS·CARCINOMA OF BREAST·+6
SAGENT PHARMACE
THIOTEPA
ALKYLATING AGENTS·CARCINOMA OF BREAST·+6
WEST-WARD,INC./
THIOTEPA
ALKYLATING AGENTS·CARCINOMA OF BREAST·+6
Hikma Pharmaceuticals USA
THIOTEPA
ALKYLATING AGENTS·CARCINOMA OF BREAST·+6
STI PHARMA, LLC
THIOTEPA
ALKYLATING AGENTS·CARCINOMA OF BREAST·+6
MEITHEAL PHARMA
Filter & compare in the drug finder →Opens the drug finder with Pericardial malignant effusion preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPericardial malignant effusion is an oncologic complication characterized by the abnormal accumulation of fluid within the pericardial sac due to direct tumor invasion, hematogenous or lymphatic metastasis, or, rarely, primary pericardial malignancy.
This cardiovascular condition predominantly affects patients with advanced systemic cancers, most commonly lung adenocarcinoma, breast cancer, lymphoma, and melanoma.
Pathophysiologically, neoplastic infiltration impairs lymphatic drainage and stimulates exudative fluid production, progressively increasing intrapericardial pressure.
This process compromises ventricular filling and cardiac output, frequently manifesting with progressive dyspnea, chest discomfort, and a high risk of life-threatening cardiac tamponade.
- nih.gov
Pericardial malignant effusion is an oncologic complication characterized by the abnormal accumulation of fluid within the pericardial sac due to direct tumor invasion, hematogenous or lymphatic metastasis, or, rarely, primary pericardial malignancy
- nih.gov
Pericardial malignant effusion is an oncologic complication characterized by the abnormal accumulation of fluid within the pericardial sac due to direct tumor invasion, hematogenous or lymphatic metastasis, or, rarely, primary pericardial malignancy This cardiovascular condition predominantly affects patients with advanced systemic cancers, most commonly lung adenocarcinoma, breast cancer, lymphoma, and melanoma Pathophysiologically, neoplastic infiltration impairs lymphatic drainage and stimula...
- cancer.gov
Pericardial malignant effusion is an oncologic complication characterized by the abnormal accumulation of fluid within the pericardial sac due to direct tumor invasion, hematogenous or lymphatic metastasis, or, rarely, primary pericardial malignancy This cardiovascular condition predominantly affects patients with advanced systemic cancers, most commonly lung adenocarcinoma, breast cancer, lymphoma, and melanoma Pathophysiologically, neoplastic infiltration impairs lymphatic drainage and stimula...
- nih.gov
Pathophysiologically, neoplastic infiltration impairs lymphatic drainage and stimulates exudative fluid production, progressively increasing intrapericardial pressure
- nih.gov
This process compromises ventricular filling and cardiac output, frequently manifesting with progressive dyspnea, chest discomfort, and a high risk of life-threatening cardiac tamponade
- nih.gov
This process compromises ventricular filling and cardiac output, frequently manifesting with progressive dyspnea, chest discomfort, and a high risk of life-threatening cardiac tamponade
Personalize your experience
Follow Pericardial malignant effusion and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.